Literature DB >> 21934337

Patterns of skin and soft tissue metastases from breast cancer according to subtypes: relationship between EGFR overexpression and skin manifestations.

Jee Hyun Kong1, Yeon Hee Park, Jung A Kim, Jeong Hoon Kim, Jina Yun, Jong Mu Sun, Young Woong Won, Soohyeon Lee, Seung Tae Kim, Eun Yoon Cho, Jin Seok Ahn, Young-Hyuck Im.   

Abstract

OBJECTIVES: We evaluated whether skin changes and soft tissue infiltration patterns reflect breast cancer subtypes based on the breast hormonal receptor (HR) and human epidermal growth factor receptor 2 (HER2) status at the time of skin metastasis.
METHODS: We retrospectively reviewed the patients' medical records with radiologic imaging studies.
RESULTS: The numbers of patients of each subtype were as follows: HR positive (HR+ve) 53 (42.4%), HER2 enriched 43 (34.4%), and triple negative (TN) 29 (23.2%). The presence of skin ulceration was found more commonly in the HR+ve group than in the others (57.1% for HR+ve vs. 25% for HER2 enriched vs. 15.4% for TN, p = 0.019). Erythematous infiltrations were shown predominantly in the TN group (19.0 vs. 54.2 vs. 84.6%, respectively, p < 0.000). On CT scans, soft tissue infiltration appeared to be more common in the HER2-enriched and TN groups than in the HR+ve group (24.5 vs. 41.9 vs. 48.3%, respectively, p = 0.013). Erythematous infiltrative lesions were more common in patients with epidermal growth factor receptor overexpression (p = 0.036).
CONCLUSION: The patterns of skin involvement including surrounding soft tissue infiltration may reflect breast cancer subtype. Prospective evaluation is necessary to confirm their influential effect on breast cancer subtypes.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934337     DOI: 10.1159/000331417

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  8 in total

1.  Triple-negative breast cancer that progressed as estrogen receptor-positive skin metastases.

Authors:  Sang Min Lee; Eun Jin Kang; Ju Hee Kim; Jong Min Yun; Der Sheng Sun; Yoon Ho Ko; Hye Sung Won
Journal:  Korean J Intern Med       Date:  2015-04-29       Impact factor: 2.884

2.  Cutaneous metastases of breast cancer during adjuvant chemotherapy correlates with increasing CD44+/CD24- and ALDH-1 expression: a case report and literature review.

Authors:  Jung Sun Lee; Woo Gyeong Kim
Journal:  Stem Cell Investig       Date:  2018-03-27

3.  Case series of different onset of skin metastasis according to the breast cancer subtypes.

Authors:  Junhyeon Cho; Yohan Park; Jong-Chan Lee; Woo Jin Jung; Soohyeon Lee
Journal:  Cancer Res Treat       Date:  2014-04-22       Impact factor: 4.679

4.  Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.

Authors:  Nan Wang; Lin Li; Youyi Xiong; Jiangrui Chi; Xinwei Liu; Chaochao Zhong; Fang Wang; Yuanting Gu
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

5.  Diagnosis and guidance of treatment of breast cancer cutaneous metastases by multiple needle biopsy: A case report.

Authors:  Zhong-Hui Li; Fang Wang; Ping Zhang; Peng Xue; Shi-Jie Zhu
Journal:  World J Clin Cases       Date:  2022-01-07       Impact factor: 1.337

6.  Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases.

Authors:  Silvia González-Martínez; David Pizarro; Belén Pérez-Mies; Tamara Caniego-Casas; José Luis Rodríguez-Peralto; Giuseppe Curigliano; Alfonso Cortés; María Gión; Javier Cortés; José Palacios
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

Review 7.  Cutaneous metastasectomy: Is there a role in breast cancer? A systematic review and overview of current treatment modalities.

Authors:  Samantha Huang; Vishwas Parekh; James Waisman; Veronica Jones; Yuan Yuan; Nayana Vora; Richard Li; Jae Jung; Laura Kruper; Farah Abdulla; Yuman Fong; Wai-Yee Li
Journal:  J Surg Oncol       Date:  2022-04-07       Impact factor: 2.885

8.  Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?

Authors:  Vincenzo Graziano; Maria Teresa Scognamiglio; Marinella Zilli; Jamara Giampietro; Patrizia Vici; Clara Natoli; Antonino Grassadonia
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.